Article (Scientific journals)
Use of Home-Based Connected Devices in Patients With Cystic Fibrosis for the Early Detection and Treatment of Pulmonary Exacerbations: Protocol for a Qualitative Study.
Morsa, Maxime; Perrin, Amélie; David, Valérie et al.
2021In JMIR Research Protocols, 10 (8), p. 14552
Peer Reviewed verified by ORBi
 

Files


Full Text
Morsaetal_JMIR-P_MucoExcet-Protocol_Aout2021.pdf
Publisher postprint (384.14 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
connected devices; cystic fibrosis; patient education; pulmonary exacerbation; self-management; Qualitative Research; Intervention Research; Grounded Theory
Abstract :
[en] Background: Early detection of pulmonary exacerbations (PEx) in patients with cystic fibrosis (CF) is important to quickly trigger treatment and reduce respiratory damage. We hypothesized that using home-based and wearable connected devices (CDs) and educating patients to react in case of abnormal variations in a set of parameters would allow patients to detect and manage their PEx early with their care team. Objective: This qualitative study aimed to assess the feasibility and appropriate conditions of a new PEx management process from the users' point of view by analyzing the experience of patients and of CF center teams regarding the education program, the use of CDs, and the relationship between the patient and the care team during PEx management. Methods: We have been conducting a multicenter pilot study involving 36 patients with CF aged ≥12 years. The intervention was divided into 3 phases. In phase 1 (3 months), patients were equipped with CDs, and their parameters were collected on 3 nonconsecutive days each week. Phase 2 involved the development of a "React to PEx" educational program aimed at providing patients with a personalized action plan. A training session to the educational program was organized for the physicians. Physicians then determined the patients' personalized alert thresholds by reviewing the data collected during phase 1 and their patients' clinical history. In phase 3 (12 months), patients were educated by the physician during a clinic visit, and their action plan for reacting in timely fashion to their PEx signs was defined. Education and action plans were revised during clinic visits. At the end of the project, the patients' experience was collected during semistructured interviews with a researcher as part of the qualitative study. The experience of CF teams was collected during focus groups using a semistructured guide once all their patients had finished the study. The interviews and focus groups were recorded and transcribed verbatim to be analyzed. Data from educational sessions were collected throughout the educational program to be put into perspective with the learnings reported by patients. Analyses are being led by 2 researchers using NVivo (QSR International). Results: The study received the favorable reception of the Committee for the Protection of Persons (CPP NORTH WEST III) on June 10, 2017 (#2017-A00723-50). Out of the 36 patients included in phase 1, 27 were educated and entered phase 3. We completed collection of all data from the patients and care providers. Qualitative analysis will provide a better understanding of users' experience on the conditions of data collection, how useful CDs are for detecting PEx, how useful the PEx action plan is for reacting quickly, what patients learned about PEx management, and the conditions for this PEx management to be sustainable in routine care. Conclusions: This study will open new perspectives for further research into the implementation of an optimal PEx care process in the organization of care teams in order to support patient self-management.
Disciplines :
Treatment & clinical psychology
Author, co-author :
Morsa, Maxime  ;  Université de Liège - ULiège > Département de Psychologie > Recherche qualitative ; The Health Education and Practices Laboratory (LEPS UR 3412), Sorbonne Paris North University, Bobigny, France
Perrin, Amélie ;  Pediatric Cystic Fibrosis Center, Nantes University Hospital, Nantes, France
David, Valérie ;  Pediatric Cystic Fibrosis Center, Nantes University Hospital, Nantes, France
Rault, Gilles ;  The Health Education and Practices Laboratory (LEPS UR 3412), Sorbonne Paris North University, Bobigny, France
Le Roux, Enora ;  Unité Mixte de Recherche 1123 Epidémiologie Clinique et EValuation Economique appliquées aux populations vulnérables, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France ; Centre d'Investigation Clinique 1426 Unit of Clinical Epidemiology, Hôpital Universitaire R Debré, Assistance Publique des Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France
Alberti, Corinne ;  Unité Mixte de Recherche 1123 Epidémiologie Clinique et EValuation Economique appliquées aux populations vulnérables, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France ; Centre d'Investigation Clinique 1426 Unit of Clinical Epidemiology, Hôpital Universitaire R Debré, Assistance Publique des Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France
Gagnayre, Rémi ;  The Health Education and Practices Laboratory (LEPS UR 3412), Sorbonne Paris North University, Bobigny, France
Pougheon Bertrand, Dominique ;  The Health Education and Practices Laboratory (LEPS UR 3412), Sorbonne Paris North University, Bobigny, France
Language :
English
Title :
Use of Home-Based Connected Devices in Patients With Cystic Fibrosis for the Early Detection and Treatment of Pulmonary Exacerbations: Protocol for a Qualitative Study.
Publication date :
2021
Journal title :
JMIR Research Protocols
eISSN :
1929-0748
Publisher :
JMIR Publications Inc., Canada
Volume :
10
Issue :
8
Pages :
e14552
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
This research benefited from additional funding from Vertex Pharmaceuticals in the form of a Circle of Care charitable grant attributed in 2016 to a project entitled “A pilot experience to assess the feasibility of the use of electronic devices to allow educated adults with CF to get more involved in their own health care”.Funding was provided by FRM to the entire project entitled “Use of home-based connected devices in the early detection and treatment of pulmonary exacerbations: Feasibility and clinical validity in cystic fibrosis patients” (“Évaluation de l’utilisation des objets connectés pour la détection précoce et le traitement des exacerbations respiratoires des patients Mucoviscidose”) in the framework of the call for Project “Évaluation de l’impact des objets connectés sur la santé” (FRM decision for funding was delivered on November 18, 2016).Funding for this study is from 2 main sources: Fondation pour la Recherche Médicale (FRM), who provided €173,970 (US $205,925), and Grant Vertex Pharmaceuticals, who provided €12,105 (US $14328). The Nokia Foundation (Withings) donated the CDs used for the study.
Available on ORBi :
since 27 September 2023

Statistics


Number of views
6 (2 by ULiège)
Number of downloads
5 (1 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
1
OpenCitations
 
3

Bibliography


Similar publications



Contact ORBi